Read More 1 minute read Hiring News News Cellares Appoints Ossama Eissa as COO to Scale Global Cell Therapy Manufacturing Key Highlights Ossama Eissa joins Cellares as COO to expand global cell therapy manufacturing. Eissa brings over 20 years of… byChris-Anne RoqueNovember 15, 2024
Read More 1 minute read Contracts News Kite to Evaluate Cellares’ Automated Cell Shuttle Platform Key Highlights Kite evaluates Cellares’ automated Cell Shuttle platform. Proof-of-concept evaluation to assess future manufacturing viability. Potential to… byChris-Anne RoqueJuly 8, 2024
Read More 1 minute read Growth News News Bristol Myers Squibb Partners with Cellares in $380M CAR T Cell Therapy Deal Key Highlights Worldwide agreement worth up to $380M includes capacity reservation and supply for CAR T cell therapies. Cellares… byChris-Anne RoqueApril 23, 2024
Read More 1 minute read News Product News Cellares Unveils Automated QC Solution, Cell Q™ Key Highlights Cell Q™ automates quality control, drastically increasing throughput with capacity for up to 6,000 batches/year. Designed… byChris-Anne RoqueApril 21, 2024
Read More 2 minute read Funding News News Cellares’ Series C Fundraising Triumph: Launching a New Smart Factory in Somerset County Key Highlights $255 million series C fundraise by Cellares for launching a 118,000-sq. ft. manufacturing site in Bridgewater, New Jersey. The… byChris-Anne RoqueJanuary 29, 2024
Read More 1 minute read Funding News News Cellares Secures $255M Series C Funding to Revolutionize Cell Therapy Manufacturing Cellares, a pioneering force in cell therapy manufacturing, has announced a successful $255 million Series C funding round.… byJared S. TaylorAugust 23, 2023